Skip to main content
. 2018 Apr 9;3(3):265–270. doi: 10.1016/j.adro.2018.04.001

Table 2.

Subgroup characteristics of patients who received hypofractionation

ASTRO-endorsed cohort Directive-endorsed cohort
T stage T1-T2 Tis-T2
N stage N0 N0-Nmi
Age ≥50 No limit
Prior chemotherapy No No

ASTRO, American Society for Radiation Oncology.